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ABSTRACT 
Eugenol, both in its pure form (EG) and included in essential clove oil (CO) was successfully solubilized in aqueous 
solution by forming inclusion complexes with β-cyclodextrins (β-CDs) and its modified hydroxypropyl-β-CDs 
(HP-β-CDs). To investigate the molecular association between β-CDs/HP-β-CDs with pure EG and essential CO, phase 
solubility studies were undertaken. Essential CO formed insoluble complexes with β-CDs, but not with HP-β-CDs. The 
work clearly demonstrates complexes formation follow an order higher than 1:1 when high essential CO and β-CDs 
concentrations were used, however it was 1:1 in the case of essential CO-HP-β-CDs complexes. When pure EG was 
studied the results indicated that EG could form 1:1 inclusion complexes with β-CDs and HP-β-CDs. Based on the 
studies, the Kc values for pure EG were 4555 ± 225 M−1 and 10,633 ± 614 M−1 for β-CDs and HP-β-CDs, respectively, 
and 2005 ± 199 M−1 for essential CO-HP-β-CDs. These finding indicate that CDs are suitable for encapsulating EG.  
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1. Introduction 
Essential oils and extracts of various species of edible 
and medicinal plants, herbs, and spices constitute very 
potent biologically active agents. They have a complex 
composition, containing from a few to several hundred 
constituents, mainly hydrocarbons and oxygenated com- 
pounds. Both, hydrocarbons and oxygenated compounds 
are responsible for the characteristic odors and flavors, 
which are formed by aromatic plants as secondary me- 
tabolites [1]. 
Clove oil (CO) is an essential oil from the dried flower 
buds, leaves and stem of the tree Syzygium aromaticum 
(Eastern Hemisphere) or Eugenia caryophyllata and 
Eugenia aromaticum (Western hemisphere) [2]. It has 
been used for centuries as anesthetic for toothaches, 
headaches and joint pain [3,4]. Clove has received atten-
tion as an ideal fish anaesthesic [5-8] and it has been 
used as a fragrant and flavoring agent in a variety of food 
and cosmetic products [9-11]. However, irritation to- 
wards the mucosa and skin, pungent taste, volatility, light 
sensitivity and poor water solubility make it unsuitable to 
use as such.  
Eugenol (EG) (4-allyl-2-methoxyphenol) is the prin- 
cipal constituent of the essential CO, being 90% - 95% of 
the total oil amount [12,13]. It has a strong phenolic 
smell and sharp acrid taste [14,15] and its chemical 
structure is represented in Figure 1.  
This phenolic compound has shown several biological 
activities such as anti-inflammatory activity, by inhibiting 
the enzyme ciclooxygenase II [16]; analgesic activity, 
due to selective binding at capsaicin receptor [17]; anti- 
oxidative activity and anti-bacterial activity, against both 
gram positive and gram negative microorganisms [18- 20].  
It is well established that cyclodextrins (CDs) form 
complexes with several molecules eliminating their un- 
wanted effects. CDs are a group of naturally occurring 
cyclic oligosaccharides derived from starch with six, 
seven and eight glucose of residues linked by α (1 - 4) 
glycosidic bonds in a cylinder-shaped structure, and de- 
nominated α, β and γ-cyclodextrins, respectively. The 
central cavity of these molecules is hydrophobic, while 
the rims of the surrounding walls are hydrophilic. This 
hydrophobic cavity forms inclusion complexes with a 
wide range of organic and inorganic guest molecules [21], 
altering their physicochemical behavior and reducing 
their undesirable effects.  
The inclusion of eugenol in CDs has been widely  *Corresponding author. 
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Figure 1. Chemical structure of eugenol (EG). 
 
studied [22-25]. These inclusion complexes have been 
mainly characterized by using fluorescence and infrared 
spectroscopy (IR) [23,24], UV-visible spectroscopy (UV), 
powder X-Ray diffraction (XRD), thermogravimetric 
analysis (TA), differencial scanning calorimetry (DSC) 
and nuclear magnetic resonance spectroscopy (NMR) 
[22-24]. However, the majority of these studies are fo-
cused in the complexation of pure EG, but not in the 
complexation of this as main component of essential CO. 
In the food industry, clove is often used in the form of 
ground, extracted essential oil or oleoresin, but always in 
a small amount because of its intense flavour. However, 
the use of CO could be a problem in industrial food ap-
plications due to its high volatility and low stability.  
In order to optimize and design controllable and ad- 
vanced essential CO-CDs carriers for food, cosmetic and 
other industrial applications it is necessary to study the 
complexes formation process between CDs and essential 
CO. The aim of the present work was to characterize the 
complexation process between pure EG and this when it 
is included in the essential CO with native β-CDs or its 
modified Hydroxypropyl-β-CDs (HP-β-CDs), by GC-MS 
analyses and spectrophotometric studies.  
2. Materials and Methods 
2.1. Materials 
β-CDs were purchased from Wacker (Germany) and 
HP-β-CDs were supplied from TCI (Europe). Essential 
CO was kindly supplied by Lidervet, SA (Spain). EG 
was obtained from Sigma-Aldrich (Spain). All other 
chemicals used were of analytical grade.  
2.2. Methods 
2.2.1. Solubility Studies 
Phase solubility studies were carried out according to the 
method described by Higuchi and Connors (1965). Ex-
cess amount of essential CO or pure EG were added to 
aqueous solutions of increasing concentrations of β-CDs, 
up to 13 mM, or HP-β-CDs up to 75 mM, in a final vol-
ume of 5 mL of water, at 25˚C. The samples were main-
tained in an ultrasonic bath at 25˚C to reach equilibrium. 
Later on, the tubes were shaken in a vortex. 500 mM of 
NaCl were added to each sample to accelerate the pre-
cipitation. Samples were centrifuged at 14,800 g at 25˚C 
for 30 min in a centrifuge model Biofuge Stratos. The 
supernatants were filtered through 0.2 µm nylon mem-
brane filter and diluted in 80% ethanol prior to the quan-
tification of the encapsulated pure EG or essential CO in 
solution by UV-spectrophotometry or GC-MS analysis. 
When a precipitated was observed, it was redissolved by 
adding 2 mL of ethanol 100%. The samples were then 
centrifuged at 14,800 g at 25˚C for 30 min. These super-
natants were used for the quantification of the essential 
CO by GC-MS or UV-spectrophotometry analysis. The 
results obtained for supernatants or precipitates were 
plotted vs CDs concentration and the apparent stability 
constants, Kc, for essential CO or pure EG and β-CDs or 
Hp-β-CDs inclusion complexes were calculated from the 
slopes and intercept of the linear portion of the phase 
solubility diagrams, according to the following equation 
[26]: 








             (2) 
where S0 is the aqueous solubility of essential CO or pure 
EG, in the absence of CDs and the slope means the cor- 
responding slope of the phase solubility diagrams, i.e. the 
slope of EG as main component of essential CO or pure 
EG vs β-CDs or HP-β-CDs concentration graph. The 
dissolved essential CO or pure EG in each sample, were 
obtained by using calibration curves prepared in the same 
experimental conditions by GC-MS or UV-spectrophoto- 
metry analysis. 
2.2.2. Capillary GC-MS Analysis 
The GC used was a Shimadzu GC-QP 2010 (Kyoto, Ja-
pan) coupled with a mass spectrometer. Helium was used 
as the carrier gas at an average flow rate of 0.5 mL/min. 
The capillary column used was a ω-WAX 250 fused sil-
ica supelco (30 m × 0.25 mm × 0.25 µm of thickness). 
For individual analite identification and quantification, 
the temperature was as follows: 3 min at 40˚C, raised up 
to 47˚C at 2˚C/min, held at 47˚C for 2 min, raised up to 
52˚C at 2˚C/min, from 52˚C to 110˚C at 5˚C/min, ramped 
at 25˚C/min up to 200˚C and keep finally at 200˚C for 5 
min. Peak areas of each compound were used for quanti-
fication of EG.  
In the first set of experiments and in order to obtain the 
signal for the analite in the mass spectrometer, a control 
sample of essential CO was spiked. As it is known the 
main compound of essential CO was eugenol [12], which 
was used to prepare a calibration curve (Figure 2). Three 
replications were made for each measurement and stan-
dard error was not higher than 5%.  
2.2.3. UV-Spectrophotometric Analyses 
Formation of the inclusion complexes was verified spec-
trophotometrically in a Shimadzu model UV-1603 spec-
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trophotometer at the absorption maximum of the essen- 
tial CO, which was coincident with that for EG at 282 
nm (Figure 3).  
For this purpose calibration curves were prepared by 
using increasing concentrations of essential CO and pure 
EG ethanolic solution (from 0.005 to 0.05 mg/mL).  
3. Results and Discussion  
Prior to the aqueous solubility studies of essential CO in 
the presence of CDs, a GC-MS characterization of essen- 
tial CO was carried out. The major peak obtained was  
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Figure 2. Essential CO (●) calibration curve by GC-MS. 
Inset: Total ion chromatogram of essential CO representing 
the main compound, eugenol (EG), of essential CO.  
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Figure 3. UV-Vis absortion spectra of increasing concentra-
tions of essential CO (0.04, 0.03 mg/mL) (a, b, solid line) 
and pure EG (0.04 - 0.05 mg/mL) (c, d) discontinue line. 
EG (Figure 2, inset), as could be demonstrated by the 
mass spectrum (data not shown). The pure compound 
(EG) was spiked and a calibration curve was prepared 
(Figure 2).  
Once the main compound of essential CO was identi- 
fied, its UV-spectrum was study. Pure EG absorption 
spectra were the same that absorption spectra of essential 
CO, showing a maximum at 282 nm (Figure 3). The 
slope of both, essential CO and pure EG, calibration 
curves were very similar (Essential CO: y = 0.014 + 
13.8x; EG: y = 0.021 + 15.91x) (Figure 4). 
Therefore, either the calibration curve of pure EG ob-
tained by GC-MS (Figure 2) or by spectrophometry 
(Figure 4, open squares) were used to know the concen-
tration of encapsulated essential CO in CDs solution and 
to compare the efficiency of both methods in EG quanti-
fication, due to the fact that the main compound of es-
sential CO is EG.  
3.1. Methods Validation 
First of all, the validation of EG quantification methods 
used in this study (GC-MS and UV-spectrophotometry) 
was carried out. 
3.1.1. Linearity 
Figures 2 and 4 (open squares), show the linear relation- 
ship between absorbance at 282 nm or the peak area for 
UV-spectophotometry or GC-MS analysis of pure EG, 
respectively. The regression analysis in Figure 4 (open 
squares) and Figure 2 points to the linear response between 
the EG concentration and the peak area or absorbance at  
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Figure 4. Essential CO (●) and pure EG (□) calibration 
curve at 282 nm Inset: Absortion spectra of pure EG from 
2.2 × 10−3 to 0.05 mg/mL. a to f represent the increasing 
pure EG concentrations. 
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282 nm, yielding the following equations:  
y = 242022 + 1516664x (GC-MS)            (1) 
y = 0.021 + 15.91x (UV-Spectrophotometry)   (2) 
with a correlation coefficient r2 of 0.999 for both, GC- 
MS and UV-spectrophotometric analysis (Table 1). 
3.1.2. Limit of Quantification (LOQ) and Limit of 
Detection (LOD) 
The limit of detection or least detectable dose (LOD) is 
the smallest concentration of the analyte that produces a 
signal significantly different from zero with a stated de- 
gree of confidence. There is a general consensus in favor 
of selecting the analyte dose providing 3 times the stan- 
dar deviation (SD) from the mean measurement of the 
blank dose signal. The LOD for GC-MS or spectropho- 
tometric method was stimed by analysis of five sets of 12 
replicates of the zero standars. The mean peak area or 
absorbance at 282 nm values plus 3-fold SD correspond 
to an estimated limit of detection of 3.2 × 10−4 and 2.2 × 
10−3 mg/mL of EG for GC-MS and spectrophotometric 
analysis, respectively (Table 1). 
The limit of quantification (LOQ) is the smallest con- 
centration of analyte that can be measured in samples so 
as to yield a predicted concentration with a stated relative 
precision and accuracy. Commonly, the selected LOQ is 
defined by the mean peak area or absorbance at 282 nm 
value plus 10-fold SD. The LOQ of both methods were 
calculated on the basis of the analysis of 20 samples with 
1.1 × 10−3 mg/mL for GC-MS analyses and 7.2 × 10−3 
mg/mL for spectrophotometric analyses (Table 1). 
3.1.3. Precision 
Assay precision was tested by repeatability (intraday 
variation) and reproductibility (interday variation) studies. 
Six samples were fortified at 5 mg/mL for GC-MS and 
25 µg/mL for spectrophotometric analyses, and EG con-
centration was measured 6 times (by triplicate), on the 
same day (repeatability) and of five different days (re-
producibility). The SD and intra and interday coefficient 
variation (% CV) of the peak area for GC-MS and ab-
sorbance at 282 nm for spectophotometric values were 
calculated giving values of 1.5% and 4.6% for GC-MS 
analyses and 1.1% and 4.1% for spectrophotometric ana- 
lyses (Table 1).  
3.1.4. Ruggedness 
To determine the ruggedness of both GC-MS and spec-
trophotometric methods, 5 mg/mL of EG for GC-MS 
analyses and 25 µg/mL of EG for spectrophotometric 
analyses, were analyzed for 30 days, during which peak 
area and absorbance at 282 nm presented a CV of 6.3% 
for GC-MS and 6.6% for spectrophotometry, confirming 
the reliability of both assays (Table 1).  
3.2. Complexation Study 
When the aqueous solubility of essential CO was studied 
in the presence of increasing CDs concentrations, differ-
ent patrons of behavior were observed in the presence of 
the native β-CDs vs the modified HP-β-CDs.  
In the case of β-CDs (Figure 5, filled circles), the total 
essential CO (refers always to its main compound EG 
concentration) dissolved increased with β-CDs concen-
trations up to 2 mM. At this point, the maximum level of 
essential CO in solution was reached (12 mM). Above 
β-CDs 2 mM, the essential CO concentration decreased 
until reach a constant level of 6 mM, creating a B-type 
phase-solubility profile. These results indicated the for-
mation of CO-β-CDs complexes with limited aqueous 
solubility (typical for native β-CDs).  
Specifically, phase solubility diagram obtained was a 
Bs-type. As shown in Figure 5, β-CDs concentration 
above 2 mM did not improve the essential CO solubility. 
The solubility limit of essential CO-β-CDs complexes 
were reached at β-CDs 2 mM and 12 mM of essential CO 
and further addition of CDs resulted in the formation of 
less soluble inclusion complexes as has been previously 
described by Grant and Higuchi (1990) [27]. At this 
point (12 mM of essential CO) no more essential CO-β- 
CDs soluble inclusion complexes were formed, and fur-
ther addition of β-CDs led to the precipitation of less 
soluble complexes. Over 2 mM β-CDs concentration, a 
gradually increase in essential CO-β-CDs insoluble com-
plexes were produced until reach a maximum essential 
CO level of 550 mg/g precipitate (Figure 5, open circles). 
Waleczek, et al. in 2002 [28] reported a phase solubility 
study of camomile essential oil with β-CDs and its major 
compound β-bisabolol, obtaining also B-type profiles. 
To further investigate, the complexation of pure EG, 
the major compound of essential CO, with β-CDs was 
carried out. Surprisingly, the profile of pure EG using  
 
Table 1. Values of more representative validation parameters. 
Precision (%) 
Method Linearity (mg/mL) LOD (mg/mL) LOQ (mg/mL) 
Interday Intraday 
Ruggedness (%)
GC-MS 0.5 – 30 3.2 × 10−4 ± 0.004 1.1 × 10−3 ± 0.003 4.6 1.5 6.3 
Spectr. 5.5 × 10−3 – 0.05 2.2 × 10−4 ± 0.005 7.2 × 10−3 ± 0.007 4.1 1.1 6.6 
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β-CDs (Figure 6, open squares) was not exactly the same 
as that obtained for essential CO (Figure 6, filled circles) 
in the solubility studies. 
In the case of pure EG the saturation level of dissolved 
compound was 12 mM and it was reached with 2 mM 
β-CDs concentration. It is important to note that at this 
point (β-CDs 2 mM) the complexation of essential CO 
also reached its maximum solubility level (12 mM).  
  Despite of the fact of reaching a constant level of pure 
EG-β-CDs soluble complexes, no precipitate was ob- 
served when β-CDs concentration increased above 2 mM 
(Figure 6, open squares), comparing with essential CO 
(Figure 6, filled circles). Looking at the phase solubility  
  
CDs (mM)












































Figure 5. Phase solubility diagram for essential CO in 
presence of increasing β-CDs concentrations: soluble (●) 
and insoluble (○) essential CO-β-CDs complexes.  
  
-CDs (mM) 



























Figure 6. Phase solubility diagram for pure EG and essen-
tial CO in the presence of increasing β-CDs concentrations: 
pure EG-β-CDs complexes (□) and soluble essential CO-β- 
CDs complexes (●). 
profile of pure EG showed in Figure 6 (open squares), 
the results clearly demonstrate that the complexation 
limit of pure EG with β-CDs was reached, however, the 
use of β-CDs concentration below its aqueous solubility 
limit (13 mM) did not permite us to see the formation of 
pure EG-β-CDs insoluble complexes. 
These results could be explained by the presence of 
other essential CO minority compounds which although 
prevent the complexation process between EG and β- 
CDs they dismishes the EG-β-CDs complexes solubility. 
Similar effect was previously described by Waleczek et 
al. (2002) [28] for camomile essential oil.  
When the slope value of the linear portion of phase 
solubility diagram of pure EG was calculated (0 - 2 mM 
β-CDs) (Figure 6, open squares), it was approximately 5, 
indicating the formation of complexes with stoichiometry 
higher than 1:1 with respect to EG. 
To further investigate the relation between binding of 
pure EG and β-CDs, the complexation behavior of solu-
ble pure EG at low β-CDs was examinated by spectro-
photometric analysis. In this experiment the concentra-
tion of pure EG was kept constant at 0.07 mM and the 
CDs concentration ranged from 0 to 3 mM. When in-
creasing concentrations of β-CDs were added to the reac-
tion medium an exponential decay was obtained in the 
range of 0 - 1 mM of β-CDs concentration, when plotting 
the absorbance at 282 nm vs β-CDs concentration (Fig- 
ure 7). 
The absorbance at any wavelength (A) can be related 
to the CDs concentration by the equation [29]: 













           (3) 
where A∞ is the absorbance when total EG has been 
complexed in CDs and A0 is the absorbance of pure EG 
in the absence of CDs.  
Figure 7 shows that absorbance at 282 nm decreased 
at the beginning of the curve and then a slowly flattened 
out at β-CDs concentration values higher than 0.5 mM. 
This behavior suggested that the majority of EG had been 
included inside of the CDs cavity forming inclusion 
complexes. The association constant between EG-β-CDs 
was calculated asuming a 1:1 stoichiometry, by applying 
the Benesi-Hildebrand treatment to the absortion curve 
[30]:  
   0 0 0
1 1 1
CDscA A A A A A K 
 
  
    (4) 
The experimental data from Figure 7 were replotted as 
a function of 1/[CDs] vs 1/A − A0 in the new Figure 7, 
inset. Fitting the data of Figure 7 inset, to Equation (4), a 
Kc value of 10,633 ± 614 M
−1 was obtained. Zhan et al. 
(2008) [24] reported similar experiments with pure EG  
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Figure 7. Absorbance of pure EG at 282 nm in the presence 
of increasing vs β-CDs concentrations (0 to 3 mM). The line 
show the best fit to Equation (3). Inset: Benesi-Hildebrat 
plot. 
 
by using fluorescence spectroscopy, giving a smaller Kc 
value (357.46 M−1) for β-CDs. Waleczek et al. (2002) 
[29] investigated molecular association of β-CDs with a 
pure component as β-bisabolol or β-bisabolol as the ma-
jor component of camomile essential oil undertaking 
phase solubility studies with β-CDs. In contrast with our 
results, they found very similar profiles for both, giving a 
Kc values of 273 and 304 M
−1, and no insoluble com-
plexes were formed.  
It is important to note that the study of pure EG com- 
plexation with β-CDs carried out with pure EG concen- 
trations below its aqueous solubility limit (S0), clearly 
reflects the 1:1 stoichiometry complexes formation, as has 
been previously described by Yang and Lee, (2005) [23]. 
However, when the complexation studies between EG 
(pure or as essential CO) and β-CDs were carried out at 
EG concentrations above S0 and high β-CDs concentra- 
tions (until 13 mM), higher order stoichiometry inclusion 
complexes were formed (reflected by a slope > 1 in the 
phase solubility diagrams). Moreover, complexes with 
low aqueous solubility were formed even leading to the 
precipitation of them. 
In the essential CO solubility study in the presence of 
HP-β-CDs a linear response was obtained as CDs con-
centration increased (Figure 8, filled circles) showing an 
AL-type profile, previously described by Higuchi and 
Connors (1965) [26]. The Kc value for the complexes 
formation between essential CO and HP-β-CDs was cal-
culated by using the Equation (2) obtaining a value of 
2005 ± 199 M−1. This linear relationship with a slope 
value lower than 1, suggests a 1:1 stoichiometry for es-
sential CO-HP-β-CDs complexes. This linear profile is  
HP--CDs (mM)


























Figure 8. Phase solubility diagram for essential CO and 
pure EG with HP-β-CDs: essential CO-HP-β-CDs (●) and 
pure EG-HP-β-CDs (□). 
 
typical for modified β-CDs and it indicates a high aque-
ous solubility limit of the formed complexes. These re-
sults differ from those described previously for β-CDs, in 
which case insoluble essential CO-β-CDs complexes 
were formed.  
Moreover it is important to note that due to the high 
solubility of HP-β-CDs and the formed complexes it is 
possible to solubilize a high quantity of essential CO (i.e. 
70 mM using 75 mM of HP-β-CDs), whereas in the case 
of β-CDs the highest level of soluble essential CO is 12.7 
mM using 13 mM of β-CDs (its aqueous solubility limit). 
When the complexation of pure EG (the major com-
pound of essential CO) with HP-β-CDs was studied, a 
linear response was also obtained (Figure 8, open 
squares). 
The apparent stability constant, Kc, for pure EG and 
HP-β-CDs inclusion complexes were calculated and a 
value of 4555 ± 225 M−1 was obtained. Garg, Gupta, 
Prakash and Singh (2010) [31] reported results for pure 
EG-HP-β-CDs giving a stability constant four times 
smaller (1206.4 M−1) than us.  
The Kc values for pure EG and with β-CDs was higher 
than this obtained for its modified HP-β-CDs, (10,633 ± 
614 M−1 and 4555 ± 225 M−1, respectively). Whereas the 
stability constants were in the same order in all cases, 
β-CDs showed the high stability constant. Choi et al. 
(2009) [25] studied molecular inclusion with β-CDs and 
they found that β-CDs was more effective than its modi-
fied HP-β-CDs for pure EG encapsulation. It is supposed 
that the side chain of HP-β-CDs might interrupt EG in-
clusion within the cavity of HP-β-CDs molecule. 
In conclusion, this work demonstrated that EG as es-
sential CO or as pure compound could be successfully 
encapsulated with β-CDs and HP-β-CDs, but there were 
Copyright © 2012 SciRes.                                                                                  FNS 
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differences in the encapsulation characteristics. Essential 
CO with β-CDs allows the formation of insoluble com-
plexes, whereas no insoluble complexes were obtained in 
the case of HP-β-CDs. The work further make clear the 
complexes formation with an order higher than 1:1 with 
respect to EG as essential CO for β-CDs, when saturating 
essential CO and high β-CDs concentrations were used. 
The same experiment with HP-β-CDs permit a 1:1 com-
plexes formation. In global terms and despite of the fact 
that all the Kc values are in the same order of magnitude, 
pure EG showed higher values than EG encapsulated as 
essential CO. These results suggest that both β-CDs and 
its modified HP-β-CDs could be an alternative to solve 
out the practical application of the essential CO and at 
the same time facilitate the controlled release of its con-
stituents in food and medical industries. 
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